Spots Global Cancer Trial Database for Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors

Official Title: Vaginal Prasterone In The Treatment Of Vaginal Atrophy In Patients With Breast Cancer Treatment With Aromatase Inhibitors (Vibra Study)

Study ID: NCT04705883

Conditions

Vulvar Atrophy

Breast Cancer

Genitourinary Syndrome of Menopause

Interventions

Prasterone (DHEA), Micronized

Study Description

Brief Summary: VAGINAL PRASTERONE in the treatment of VAGINAL ATROPHY IN PATIENTS WITH BREAST CANCER TREATMENT WITH AROMATASE INHIBITORS (VIBRA STUDY)

Detailed Description: Verify a clinical improvement of AVV without increasing levels of ultrasensitive blood estradiol in breast cancer survivors treated with aromatase inhibitors by administering vaginal prasterone.